Pain management system

Smiths Medical, has released the CADDSolis ambulatory infusion pump version 4.1, which the medical device manufacturer says sets the foundation for wireless communication globally.

The CADD-Solis v4.1 pump is ULmarked and has full compliance with the latest product standards, including IEC60601-1 Edition 3.1. The CADD-Solis pump maintains the advantages of an ambulatory pump for patient mobility and also provides a single system that delivers IV PCA, epidurals and peripheral nerve blocks from pump to patient.

New features include: longer drug names to eliminate abbreviating or truncating drug names and concentrations; the addition of profiles to categorise drug protocols or represent care areas; and wireless two-way communication with the PharmGuard Server software.

Users can continue to use previous versions or choose to upgrade any CADD-Solis model 2110 pump2 to CADD-Solis v4.1 software, using SureLink remote support software, while maintaining their existing drug library. Turning off wireless communications or the lack of wireless access does not impact pump delivery or data retention.

 

 

More about Smiths Medical Ltd

 

Other news

Upcoming Events

BSA Annual Conference 2019: Translating Research into Practice

Molineux Stadium, Wolverhampton
Wednesday 5th June

Sepsis + Conference 2019

National Conference Centre Birmingham
11th June

Knowlex: Patient Safety 2019

NCC Birmingham
11th June 2019

BSG Annual Meeting 2019

Glasgow
Monday 17th June to Thursday 20th June 2019

AfPP Residential 2019

York University
8th to the 11th August

Latest Issue

Clinical Services Journal

Clinical Services Journal

May 2019

Improving safety for both staff and patients

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.

CSJ Supplements

CSJ Supplements

Apr 2019

Putting patients and hospitals first

Register now to apply for regular copies of CSJ Supplements and free access to premium content, as well as our regular newsletters.